Literature DB >> 33439495

Early genetic screening uncovered a high prevalence of thalassemia among 18 309 neonates in Guizhou, China.

Mei Tan1, Yue Bai2, Xiangmei Zhang1, Jian Sun1, Chengshuang Huang1, Runmei Tian1, Yuhang Yang1, Xi Luo1, Qiong Su1, Liusong Wu1, Libo Zheng3, Jing Xia4, Hongmei Murong5, Ping Zhu6, Fan Yang2, Xiaosong Zhong2, Jindong Chen7, Yan Chen1.   

Abstract

Thalassemia is a common monogenic disease in southwestern China, especially in Guizhou province. In this study, 18 309 neonates were examined for thalassemia. The thalassemia carrier rate was 12.90%, which is associated with geographical regions, with carrier frequencies significantly differing between regions (p < 0.0001). The carrier rates for α-thalassemia and β-thalassemia were 8.91% and 3.36%, respectively. There are 22 genotypes identified among 1632 α-thalassemia cases, and 18 genotypes detected among 615 β-thalassemia cases. The birthrates of individuals with intermediate thalassemia and β-thalassemia major were 0.153% and 0.055%, respectively. Methodologically, NGS-Gap-PCR is superior to traditional detection methods, with 65 more cases detected by NGS-Gap-PCR. Since thalassemia-rich genotypes were highly prevalent in this region, early detection of thalassemia carriers would be meaningful for genetic counseling and prevention/treatment of thalassemia. NGS-Gap-PCR provides a powerful tool for neonate genetic testing and clinical diagnosis of thalassemia, especially in high-prevalence regions.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  gap-PCR; genetic counseling; hemoglobin; neonates; next-generation sequencing; thalassemia epidemiology

Mesh:

Substances:

Year:  2021        PMID: 33439495     DOI: 10.1111/cge.13923

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  3 in total

1.  Genetic screening techniques and diseases for neonatal genetic diseases.

Authors:  Lianshu Han
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-25

2.  Clinical validation of a single-tube PCR and reverse dot blot assay for detection of common α-thalassaemia and β-thalassaemia in Chinese.

Authors:  Hong-Feng Liang; Lie-Jun Li; Hui Yang; Xiang-Bin Zheng; Min Lu; Yi-Yuan Ge; Fen Lin; Long-Xu Xie; Li-Ye Yang
Journal:  J Int Med Res       Date:  2022-02       Impact factor: 1.671

Review 3.  Applications of next generation sequencing in the screening and diagnosis of thalassemia: A mini-review.

Authors:  Syahirah Amnani Suhaimi; Ihsan Nazurah Zulkipli; Hazim Ghani; Mas Rina Wati Abdul-Hamid
Journal:  Front Pediatr       Date:  2022-09-29       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.